Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Snowflake
SNOW
|
+$199M |
| 2 |
Amazon
AMZN
|
+$162M |
| 3 |
Analog Devices
ADI
|
+$104M |
| 4 |
Palantir
PLTR
|
+$94.3M |
| 5 |
Tesla
TSLA
|
+$82.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$350M |
| 2 |
Microsoft
MSFT
|
+$261M |
| 3 |
L3Harris
LHX
|
+$185M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$166M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$135M |
Sector Composition
| 1 | Technology | 27.74% |
| 2 | Healthcare | 14.18% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Dine Brands
DIN
$372M
| $2.92M | ﹤0.01% |
36,000
+1,600
| +5% | +$130K |
|
1802
Travere Therapeutics
TVTX
$2.23B
| $2.92M | ﹤0.01% |
120,200
+5,900
| +5% | +$143K |
|
1803
Customers Bancorp
CUBI
$2.33B
| $2.91M | ﹤0.01% |
67,700
+1,300
| +2% | +$55.9K |
|
1804
The Bancorp
TBBK
$3.53B
| $2.91M | ﹤0.01% |
114,400
| – | – |
|
|
CSII
1805
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.91M | ﹤0.01% |
88,600
| – | – |
|
1806
Primoris Services
PRIM
$6.63B
| $2.91M | ﹤0.01% |
118,700
+10,400
| +10% | +$255K |
|
1807
Community Health Systems
CYH
$420M
| $2.9M | ﹤0.01% |
248,226
+5,400
| +2% | +$63.2K |
|
1808
Revolution Medicines
RVMD
$8.64B
| $2.9M | ﹤0.01% |
105,500
+2,100
| +2% | +$57.8K |
|
1809
RadNet
RDNT
$5.67B
| $2.9M | ﹤0.01% |
98,900
+2,200
| +2% | +$64.5K |
|
1810
Gevo
GEVO
$401M
| $2.9M | ﹤0.01% |
436,500
| – | – |
|
|
ATCO
1811
DELISTED
Atlas Corp.
ATCO
| $2.89M | ﹤0.01% |
190,500
| – | – |
|
|
CDMO
1812
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.89M | ﹤0.01% |
134,100
| – | – |
|
1813
First Commonwealth Financial
FCF
$1.85B
| $2.89M | ﹤0.01% |
211,900
| – | – |
|
1814
OFG Bancorp
OFG
$1.97B
| $2.88M | ﹤0.01% |
114,100
+800
| +0.7% | +$20.2K |
|
|
DADA
1815
DELISTED
Dada Nexus
DADA
| $2.88M | ﹤0.01% |
143,447
-100
| -0.1% | -$2K |
|
1816
Interparfums
IPAR
$3.49B
| $2.86M | ﹤0.01% |
38,200
| – | – |
|
1817
Sturm, Ruger & Co
RGR
$601M
| $2.86M | ﹤0.01% |
38,700
| – | – |
|
1818
Nelnet
NNI
$4.51B
| $2.85M | ﹤0.01% |
36,000
| – | – |
|
1819
OceanFirst Financial
OCFC
$1.05B
| $2.85M | ﹤0.01% |
133,133
| – | – |
|
|
BLUE
1820
DELISTED
bluebird bio
BLUE
| $2.85M | ﹤0.01% |
11,511
+85
| +0.7% | +$21K |
|
1821
AMC Networks
AMCX
$346M
| $2.85M | ﹤0.01% |
61,100
+2,100
| +4% | +$97.9K |
|
1822
TriCo Bancshares
TCBK
$1.49B
| $2.84M | ﹤0.01% |
65,500
| – | – |
|
1823
Core Laboratories
CLB
$594M
| $2.84M | ﹤0.01% |
102,300
+4,000
| +4% | +$111K |
|
1824
Schneider National
SNDR
$4.3B
| $2.84M | ﹤0.01% |
124,700
| – | – |
|
1825
Viper Energy
VNOM
$6.58B
| $2.83M | ﹤0.01% |
129,500
| – | – |
|